The Claim

The AMPK inhibitor compound C reduces but does not fully abolish oleuropein aglycone-induced autophagy in human neuroblastoma cells, indicating that AMPK is a major but not exclusive mediator of this autophagic response.

Source: Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
8score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In human neuroblastoma cells, blocking AMPK with compound C decreases autophagy triggered by oleuropein aglycone, but does not stop it completely, suggesting other pathways besides AMPK also contribute to this process.

See the scientific wording

The AMPK inhibitor compound C reduces but does not fully abolish oleuropein aglycone-induced autophagy in human neuroblastoma cells, suggesting AMPK is a major but not exclusive mediator of this effect.

What the research says

1 study
  1. Study: Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight

    The study shows that a compound in olive oil turns on a cellular cleanup process called autophagy by activating a protein called AMPK. While it doesn’t test the inhibitor mentioned in the claim, it strongly suggests AMPK is the main switch — but maybe not the only one — which matches the claim.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.